1735 related articles for article (PubMed ID: 8425765)
1. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma.
Weterman MA; van Muijen GN; Ruiter DJ; Bloemers HP
Int J Cancer; 1993 Jan; 53(2):278-84. PubMed ID: 8425765
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes.
Gondo H; Kudo J; White JW; Barr C; Selvanayagam P; Saunders GF
J Immunol; 1987 Dec; 139(11):3840-8. PubMed ID: 3500230
[TBL] [Abstract][Full Text] [Related]
3. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.
Danen EH; Jansen KF; Van Kraats AA; Cornelissen IM; Ruiter DJ; Van Muijen GN
Int J Cancer; 1995 May; 61(4):491-6. PubMed ID: 7538977
[TBL] [Abstract][Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential.
Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ
Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.
Bao L; Loda M; Janmey PA; Stewart R; Anand-Apte B; Zetter BR
Nat Med; 1996 Dec; 2(12):1322-8. PubMed ID: 8946830
[TBL] [Abstract][Full Text] [Related]
7. Expression of calcyclin in human melanocytic lesions.
Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
Cancer Res; 1993 Dec; 53(24):6061-6. PubMed ID: 8261423
[TBL] [Abstract][Full Text] [Related]
8. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
9. Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.
Doi F; Chi DD; Charuworn BB; Conrad AJ; Russell J; Morton DL; Hoon DS
Int J Cancer; 1996 Feb; 65(4):454-9. PubMed ID: 8621227
[TBL] [Abstract][Full Text] [Related]
10. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas.
Yamamoto T; Gotoh M; Kitajima M; Hirohashi S
Biochem Biophys Res Commun; 1993 Jun; 193(2):706-10. PubMed ID: 8512568
[TBL] [Abstract][Full Text] [Related]
11. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
12. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.
Weterman MA; Ajubi N; van Dinter IM; Degen WG; van Muijen GN; Ruitter DJ; Bloemers HP
Int J Cancer; 1995 Jan; 60(1):73-81. PubMed ID: 7814155
[TBL] [Abstract][Full Text] [Related]
13. Sequence of a human kidney cDNA clone encoding thymosin beta 10.
McCreary V; Kartha S; Bell GI; Toback FG
Biochem Biophys Res Commun; 1988 Apr; 152(2):862-6. PubMed ID: 3365256
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of melanocytic lesions in goats and establishment of a melanoma cell line: a potential model for human melanoma.
Parsons PG; Takahashi H; Candy J; Meyers B; Vickers J; Kelly WR; Smith I; Spradbrow P
Pigment Cell Res; 1990 Dec; 3(6):297-305. PubMed ID: 2101929
[TBL] [Abstract][Full Text] [Related]
16. Thymosin beta 4 is expressed in ROS 17/2.8 osteosarcoma cells in a regulated manner.
Atkinson MJ; Freeman MW; Kronenberg HM
Mol Endocrinol; 1990 Jan; 4(1):69-74. PubMed ID: 2325669
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas.
Marshall JF; Rutherford DC; Happerfield L; Hanby A; McCartney AC; Newton-Bishop J; Hart IR
Br J Cancer; 1998 Feb; 77(4):522-9. PubMed ID: 9484806
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.
Nürnberg W; Tobias D; Otto F; Henz BM; Schadendorf D
J Pathol; 1999 Dec; 189(4):546-51. PubMed ID: 10629556
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of thymosin genes in human tumors and in the developing human kidney.
Hall AK
Int J Cancer; 1991 Jul; 48(5):672-7. PubMed ID: 2071228
[TBL] [Abstract][Full Text] [Related]
20. Differential splicing of thymosin beta 4 mRNA.
Rudin CM; Engler P; Storb U
J Immunol; 1990 Jun; 144(12):4857-62. PubMed ID: 2351831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
